Phase 3 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are scheduled to have a planned surgery to remove part of your pancreas (the left side), with or without also having your spleen removed
- You are 18 years old or older
- You are able to understand the study information and are willing to sign a consent form agreeing to take part
Who may not be able to join:
- You are under 18 years old
- You are currently pregnant
- You have had any previous surgery on your pancreas
- You have previously had surgery to remove part of your stomach, or have had a gastric bypass or sleeve gastrectomy (stomach-reducing weight loss surgery)
- You have previously had a procedure to create a connection between a stomach cyst and your stomach (confirm with trial site)
- You have had a prior procedure using a camera or ultrasound that could not be completed due to a narrowing in your food pipe or digestive tract
- You have a certain type of hiatal hernia (a condition where part of the stomach pushes into the chest) classified as Type 3 or Type 4, found either before or during surgery
- You are having additional organs removed during the same surgery, other than the pancreas, spleen, or gallbladder
- During your surgery, the surgeon needs to use a specific stitching technique to close the cut edge of the pancreas (confirm with trial site)
- You experience unexpected heavy bleeding or scarring during surgery that makes it unsafe to proceed without placing a drain inside your abdomen
- You are not able to give informed consent to take part in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Robert Simon, MD, Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
Phone: 1-866-223-8100
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Composite endpoint comparison; Composite endpoint comparison; Composite endpoint comparison; Composite endpoint comparison
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.